Thank you Naval Daver, M.D. Eunice Wang MD and Sasha for sharing your expertise.
Am extremely informative discussion with an optimistic ending!!
Go #endcancer

How can we improve the care of patients with #MDSsm ?
Looking fwd to discussing diagnosis, risk stratification, trial design, drug approvals (pharmaceutical 💔s) and of course the ever polarizing topics of dysplasia and #CCUS ….
#HOP24live

Season 2, episode 4 of Heme Reports tonight… with leading AML experts Naval Daver, M.D. Jessica Altman, MD Eunice Wang MD Dr. Sasha Perl.
We will discuss FLT3 m AML & hope to cover revised risk stratification, implications for transplant, combination therapies, new FLT3i approvals, the

What I hope to highlight during these thoughtfully planned discussions @ #HOPlive24 is that our best treatments and therapies are only as good as our diagnoses!!!
Every patient’s journey and outcome begins with their diagnosis and it’s on us to do everything we can to get it

🙌 Sanam Loghavi, MD صنم لغوی 🔬🧬, of MD Anderson Cancer Center, reflects on 'The HemOnc Pulse' Live and how it sheds a spotlight on hematopathology!

Hear what she has to say, and stay tuned for the live meeting on May 3-4 in Chicago!

📺 buff.ly/4djPXj3

#HOPLive24 chadi nabhan MD, MBA, FACP

Horning the career and contributions of Dr. Medeiros to #hemepath tonight
We are proud to be his students!!!

Thank you for highlighting the role of hematopathology and diagnostics in the care of patients with heme malignancies.
Exited to be there.
#hemepath #HOPLive24
#leusm

CD7 targetable 🎯and is expressed in ~30% of AML. Expression may change at disease progression, highlighting the need to retest. Invaluable help from super hempath Sanam Loghavi, MD صنم لغوی 🔬🧬 Sa A Wang, MD! Naval Daver, M.D. Tapan Kadia Hagop Kantarjian,MD

Read more here 👉 onlinelibrary.wiley.com/doi/10.1111/bj…

⬅️Osteoblasts (benign) vs
➡️myeloid blasts (leukemia)
Same environment 🦴 different genes 🧬
The osteoblasts seem much more friendly and social!

Silver linings over the Houston sky today 🤍
04.24.24

It was great to see everyone who attended our MPN-MDS US Focus Meeting last week! Our 5th annual meeting was better than ever with great presentations and debates all moving forward the future of treatment options for patients.

Thank you to the wonderful co-chairs,

Thank you CAPathologists and #RFEC for the invitation.
We hope to be able to answer all your questions about #hemepath and show you why it’s the absolute best subspecialty out there :)

Folks: it’s almost here: the First Annual #HemOnc Pulse LIVE from Chicago W superb faculty & stellar agenda focused on “Unanswered Questions” in Heme Malignancies.

Stay tuned as Rafael Fonseca MD 🦔🇺🇸🏜🇲🇽 Vincent Rajkumar Sanam Loghavi, MD صنم لغوی 🔬🧬 Saad Z. Usmani MD MBA FACP 🇺🇸🇵🇰 Sangeetha Venugopal MD,MS Andrew M. Evens, DO, MBA, MSc Mehdi Hamadani, MD & many more join me.

Myeloid neoplasm with <10% blasts and t(3;5)(q25.1;q34)/NPM::MLF1: A classification dilemma
Images in #Hematology from Dr. Sanam Loghavi, MD صنم لغوی 🔬🧬 and colleagues, now free to access online!
onlinelibrary.wiley.com/doi/epdf/10.10…